80 likes | 83 Views
Syridex Bio was founded on the belief that everyone deserves the opportunity to live a healthy life. For too long, deep inequities have persisted across our pharmaceutical, biotechnology, and medical systems. Despite increased public attention on the problem in recent years, progress remains far too slow. <br><br>Syridex Bio is an impact-driven, life sciences-focused firm investing in therapies that address the needs of underserved communities.<br>
E N D
Syridex Bio is an impact-driven, life sciences-focused firm investing in therapies that accelerate global health equity by addressing the needs of underserved communities. Syridex Bio was founded on the belief that everyone deserves the opportunity to live a healthy life. For too long, deep inequities have persisted across our pharmaceutical, biotechnology, and medical systems. Despite increased public attention on the problem in recent years, progress remains far too slow. At Syridex Bio, we are addressing this gap in the market by strategically investing in therapies that treat diseases disproportionately affecting minoritized communities. By financing the development of drugs and treatments addressing the world’s greatest health disparities, we are convinced that we can accelerate health equity globally and achieve strong financial returns for our investors.
ApproachApproachExplore our investment philosophy and strategy
About Us Syridex Bio was founded on the belief that everyone deserves the opportunity to live a healthy life. For too long, deep inequities have persisted across our pharmaceutical, biotechnology, and medical systems. Despite increased public attention on the problem in recent years, progress remains far too slow. At Syridex Bio, we are addressing this gap in the market by strategically investing in therapies that treat diseases disproportionately affecting underserved communities. By financing the development of drugs and treatments addressing the world’s greatest health disparities, we are convinced that we can accelerate health equity globally and achieve strong financial returns for our investors.
Founding Investment Team Squire ServanceREAD BIO
Advisory Board AnindyaRoychowdhury READ BIO Owen May READ BIO VelekaPeeples-Dyer READ BIO Kamil Ali-Jackson READ BIO Kelvin A. Baggett, MD READ BIO
Investment Approach Investment Focus We draw on our deep relationships across the global pharmaceutical and biotech industries to source innovative, best-in-class clinical stage or near-clinical stage therapies for diseases that disproportionately affect underserved communities. Then, we invest in development to bring to market novel drugs and treatments that might otherwise go undeveloped. Investment Strategy We invest along two primary strategies: venture creation and private equity. Venture Creation: Building sustainable companies around innovative products we acquire from life sciences companies and institutions Private Equity: Privatizing and creating value for undervalued public pharmaceutical and biotechnology companies Investment Team Our team is focused on accelerating health equity and eliminating health disparities around the world. MEET OUR TEAM
Contact Us info@syridexbio.com 300 Carnegie Center, Suite 150, Princeton, NJ 08540